Biological Information

Background Information:

Prostanoid receptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. The DP1 prostanoid receptor is activated by prostaglandin D2 (PGD2) and it is expressed in vascular smooth muscle, platelets, retina and hematopoietic cells. Activation of DP1 results in inhibition of platelet activation and vasodilation; they are also involved in sleep regulation. Prostanoid DP1 receptors may also play a role in immune and inflammatory responses. The potential therapeutic utilities of DP1 receptor agonists are for glaucoma, atopic dermatitis and antagonist for dyslipidemia and asthma, respectively.

No. of Assays on Panel:

2

Assays on Panel:

Family

GPCR

Name

Item

2484

Protein

DP1

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

2486

Protein

DP1

Organism

Human

Assay Sub Type

Cell Based

Family:

GPCR

Sub Family:

Prostanoid

Class:

Class A

Protein Name:

DP1

Uniprot Number:

Q13258

Gene Name:

PTGDR

Gene ID:

5729

Gene Aliases:

DP|DP1|PTGDR1

Organism:

Human

Cell Type:

CHO-K1

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Functional Mode:

Agonist & Antagonist

Detection Method:

HTRF

Testing Information

Incubation:

30 min at RT

Control Activator:

BW 245C (10 nM)

Test Concentration / Dose:

Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.

Test Sample Requirements:

Minimum for 1) Screen: 60 µL of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM finµL testing. 2) Dose Response: 90 µL of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.

Minimum Order Quantity:

16

Turnaround Time

Standard:

15 Business Days

Clinical Relevance

Therapeutic Area:

CNS/Addiction/Pain

Adverse / Beneficial Action:

Prostanoid DP receptor agonism may increase nociception, eosinophil recruitment in asthma and inhibit platelet aggregation. DP receptor antagonism may be useful in the treatment of allergic diseases and nociception as well as prolong bleeding time.

Additional Information

Brand:

LeadHunter

Testing Location:

France - Celle L'Evescault

RELATED SOLUTIONS

Item: 2484
Item: 2486
Item: 2517